EVALAN: key player in biometric sensor market
EVALAN is mentioned by Information Research Insights as a key player in the biometric sensor market.
EVALAN is mentioned by Information Research Insights as a key player in the biometric sensor market.
Check out EVALAN’s new website, which provides greater access to the wide range of IoT products and services.
EVALAN’s participation during the InfraTech2023, an international trade fair that gathers the infrastructure sector to share knowledge and innovate, was a resounding success.
Come and meet us at Infratech 2023 from the 17th to the 20th of January in Rotterdam Ahoy.
Celebrate the Joy of the Season with EVALAN and watch the Jolly video we made to express our gratitude and to share our wishes for 2023.
The EU Cybersecurity Act will help to enforce common cybersecurity standards and reassure consumers that the internet connected “things” they buy are secured.
We are inaugurating a new section in our Newsletter. Tell us your company’s IoT problem and one of EVALAN’s IoT experts will tell you how to solve it.
EVALAN is attending the Solar Solutions Düsseldorf fair which will take place in Messe Düsseldorf on November 30th and December 1st.
EVALAN is hosting a live webinar on stretchable circuit board technology for the sports and medical industries.
EVALAN is attending the IoT Tech Expo taking place in Amsterdam RAI on the 20th and 21st of September 2022.
As part of the European project NextPerception— Evalan has been developing intelligent sensing technology that will allow for continuous and remote vitality monitoring of patients.
What does a day at Evalan look like for firmware engineer Hashim, and what achievement is he most proud of? Read his answers in this interview.
An important objective of Evalan is to contribute to sustainability in various sectors with IoT. The Solar Boat project of Engineers of Innovation is in line with this.
mart patch contains new techniques that offer many possibilities within the healthcare and sports sector.
Smart devices offer new possibilities to support patients and improve their adherence to therapy. This white paper provides insight into how Sensemedic and Collabree combine their expertise to address the problem of poor treatment adherence.